198 related articles for article (PubMed ID: 33107359)
1. Understanding host immune responses to pneumococcal proteins in the upper respiratory tract to develop serotype-independent pneumococcal vaccines.
Lagousi T; Basdeki P; De Jonge MI; Spoulou V
Expert Rev Vaccines; 2020 Oct; 19(10):959-972. PubMed ID: 33107359
[No Abstract] [Full Text] [Related]
2. Identification of SP1683 as a pneumococcal protein that is protective against nasopharyngeal colonization.
Moens L; Hermand P; Wellens T; Wuyts G; Derua R; Waelkens E; Ysebaert C; Godfroid F; Bossuyt X
Hum Vaccin Immunother; 2018 May; 14(5):1234-1242. PubMed ID: 29400602
[TBL] [Abstract][Full Text] [Related]
3. Serotype-Independent Protection Against Invasive Pneumococcal Infections Conferred by Live Vaccine With
Jang AY; Ahn KB; Zhi Y; Ji HJ; Zhang J; Han SH; Guo H; Lim S; Song JY; Lim JH; Seo HS
Front Immunol; 2019; 10():1212. PubMed ID: 31191555
[No Abstract] [Full Text] [Related]
4. Intranasal Immunization with the Commensal
Shekhar S; Khan R; Schenck K; Petersen FC
Appl Environ Microbiol; 2019 Mar; 85(6):. PubMed ID: 30683742
[No Abstract] [Full Text] [Related]
5. Intranasal vaccination with chitosan-DNA nanoparticles expressing pneumococcal surface antigen a protects mice against nasopharyngeal colonization by Streptococcus pneumoniae.
Xu J; Dai W; Wang Z; Chen B; Li Z; Fan X
Clin Vaccine Immunol; 2011 Jan; 18(1):75-81. PubMed ID: 21047997
[TBL] [Abstract][Full Text] [Related]
6. Mucosal and systemic immunization with a novel attenuated pneumococcal vaccine candidate confer serotype independent protection against Streptococcus pneumoniae in mice.
Wu K; Yao R; Wang H; Pang D; Liu Y; Xu H; Zhang S; Zhang X; Yin Y
Vaccine; 2014 Jul; 32(33):4179-88. PubMed ID: 24945468
[TBL] [Abstract][Full Text] [Related]
7. Streptococcus pneumoniae serotype 19A: worldwide epidemiology.
Isturiz R; Sings HL; Hilton B; Arguedas A; Reinert RR; Jodar L
Expert Rev Vaccines; 2017 Oct; 16(10):1007-1027. PubMed ID: 28783380
[TBL] [Abstract][Full Text] [Related]
8. Impaired innate and adaptive immunity to Streptococcus pneumoniae and its effect on colonization in an infant mouse model.
Bogaert D; Weinberger D; Thompson C; Lipsitch M; Malley R
Infect Immun; 2009 Apr; 77(4):1613-22. PubMed ID: 19168741
[TBL] [Abstract][Full Text] [Related]
9. Protection against Streptococcus pneumoniae Invasive Pathogenesis by a Protein-Based Vaccine Is Achieved by Suppression of Nasopharyngeal Bacterial Density during Influenza A Virus Coinfection.
Khan MN; Xu Q; Pichichero ME
Infect Immun; 2017 Feb; 85(2):. PubMed ID: 27895132
[TBL] [Abstract][Full Text] [Related]
10. A feasibility study of controlled human infection with Streptococcus pneumoniae in Malawi.
Morton B; Burr S; Chikaonda T; Nsomba E; Manda-Taylor L; Henrion MYR; Banda NP; Rylance J; Ferreira DM; Jambo K; Gordon SB;
EBioMedicine; 2021 Oct; 72():103579. PubMed ID: 34571365
[TBL] [Abstract][Full Text] [Related]
11. IL-17A and complement contribute to killing of pneumococci following immunization with a pneumococcal whole cell vaccine.
Campos IB; Herd M; Moffitt KL; Lu YJ; Darrieux M; Malley R; Leite LC; Gonçalves VM
Vaccine; 2017 Mar; 35(9):1306-1315. PubMed ID: 28161422
[TBL] [Abstract][Full Text] [Related]
12. A Combination of Recombinant Mycobacterium bovis BCG Strains Expressing Pneumococcal Proteins Induces Cellular and Humoral Immune Responses and Protects against Pneumococcal Colonization and Sepsis.
Goulart C; Rodriguez D; Kanno AI; Converso TR; Lu YJ; Malley R; Leite LCC
Clin Vaccine Immunol; 2017 Oct; 24(10):. PubMed ID: 28768668
[TBL] [Abstract][Full Text] [Related]
13. Dendritic cell-targeting DNA-based nasal adjuvants for protective mucosal immunity to Streptococcus pneumoniae.
Kataoka K; Fukuyama Y; Briles DE; Miyake T; Fujihashi K
Microbiol Immunol; 2017 Jun; 61(6):195-205. PubMed ID: 28463465
[TBL] [Abstract][Full Text] [Related]
14. Mucosal immunization with polyamine transport protein D (PotD) protects mice against nasopharyngeal colonization with Streptococcus pneumoniae.
Shah P; Briles DE; King J; Hale Y; Swiatlo E
Exp Biol Med (Maywood); 2009 Apr; 234(4):403-9. PubMed ID: 19176871
[TBL] [Abstract][Full Text] [Related]
15. Association of Streptococcus pneumoniae common protein antigen (CPA) antibodies and pneumococcal nasopharyngeal colonization in HIV-infected and HIV-uninfected African children.
Ditse Z; Adrian PV; Kuwanda L; Madhi SA
Vaccine; 2013 Sep; 31(40):4421-7. PubMed ID: 23845819
[TBL] [Abstract][Full Text] [Related]
16. Nasal immunization of mice with Lactobacillus casei expressing the pneumococcal surface protein C primes the immune system and decreases pneumococcal nasopharyngeal colonization in mice.
Hernani Mde L; Ferreira PC; Ferreira DM; Miyaji EN; Ho PL; Oliveira ML
FEMS Immunol Med Microbiol; 2011 Aug; 62(3):263-72. PubMed ID: 21492260
[TBL] [Abstract][Full Text] [Related]
17. An important role for polymeric Ig receptor-mediated transport of IgA in protection against Streptococcus pneumoniae nasopharyngeal carriage.
Sun K; Johansen FE; Eckmann L; Metzger DW
J Immunol; 2004 Oct; 173(7):4576-81. PubMed ID: 15383591
[TBL] [Abstract][Full Text] [Related]
18. Density, Serotype Diversity, and Fitness of Streptococcus pneumoniae in Upper Respiratory Tract Cocolonization With Nontypeable Haemophilus influenzae.
Lewnard JA; Huppert A; Givon-Lavi N; Pettigrew MM; Regev-Yochay G; Dagan R; Weinberger DM
J Infect Dis; 2016 Nov; 214(9):1411-1420. PubMed ID: 27540112
[TBL] [Abstract][Full Text] [Related]
19. Relationship between immune response to pneumococcal conjugate vaccines in infants and indirect protection after vaccine implementation.
Dagan R
Expert Rev Vaccines; 2019 Jun; 18(6):641-661. PubMed ID: 31230486
[No Abstract] [Full Text] [Related]
20. Pneumococcal Carriage in Children under Five Years in Uganda-Will Present Pneumococcal Conjugate Vaccines Be Appropriate?
Lindstrand A; Kalyango J; Alfvén T; Darenberg J; Kadobera D; Bwanga F; Peterson S; Henriques-Normark B; Källander K
PLoS One; 2016; 11(11):e0166018. PubMed ID: 27829063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
